Specific stock prices and market valuations move daily and can shift dramatically in a single year — the figures here are illustrative anchors, current as of writing, and should be re-checked against a live source before being relied on. What does not move much is the structural picture: the scale of these companies and how they are organized. That is what this page is really about.
The scale
Health care is not only the country's largest area of social spending — it is home to some of the largest companies in the entire economy. The revenue flowing through the biggest health firms rivals that of the largest technology and energy companies in the world.
These are not fringe players skimming the edges of the system. They are the system's largest structures, and the dollars traced in the earlier primers — the premiums, the drug spending, the administrative overhead — are, from another angle, their revenue.
The integrated model
The most important structural fact in the market is not any single company's size. It is how the largest ones are built. The dominant firms are no longer just insurers. They are vertically integrated: a single company may own the insurance plan, the pharmacy benefit manager that negotiates drug prices, the mail-order pharmacy, and a large network of clinics and physicians employing tens of thousands of doctors.
This means the same corporate parent can insure a patient, decide what their drugs cost, fill the prescription, and provide the medical care — collecting revenue at every step. The three largest of these combined insurer-PBM-provider organizations together touch a very large share of American health care. The structure is legal, sophisticated, and, from a business standpoint, highly effective. It is also the near-perfect structural opposite of what this framework proposes.
The point of this primer is not to assign villainy — these companies operate rationally within the rules that exist, and they employ many people working in good faith. The point is simpler and factual: the enormous spending trajectory documented in this section has coincided with enormous value accumulation in the intermediary layer between patients and care. When health spending rises, that rise lands somewhere. A meaningful share of it lands here, as revenue and shareholder return in the companies that sit between the person and the care.
The framework's reading
The vertically integrated insurer-PBM-provider is the structural inverse of the cooperative model this site describes. One concentrates ownership and control upward, into a single large corporate entity that profits at every layer between the patient and the care. The other distributes ownership outward, to the community of members the clinic actually serves, and removes the intermediary layers from the primary care relationship entirely.
Neither this page nor this framework argues that these companies are the sole cause of American healthcare's problems — the execution gap runs deeper than any set of firms, and insurance has a genuine role in covering catastrophic risk. But the market view makes one thing concrete. The money documented throughout this section does not simply evaporate into inefficiency. A great deal of it accumulates, by design, in the layer between the person and their care. The cooperative's answer is to shrink that layer for primary care, so that more of each dollar reaches the exam room and the relationship, and less of it is claimed on the way.